Posts

Showing posts from July, 2020

“Coronavirus: How COVID-19 progresses; a day-by-day breakdown of symptoms - KIRO Seattle” plus 1 more

Image
“Coronavirus: How COVID-19 progresses; a day-by-day breakdown of symptoms - KIRO Seattle” plus 1 more Coronavirus: How COVID-19 progresses; a day-by-day breakdown of symptoms - KIRO Seattle Posted: 08 Apr 2020 12:00 AM PDT According to the Mayo Clinic, ARDs "happens when fluid builds up in the tiny, elastic air sacs (alveoli) in your lungs. The fluid keeps your lungs from filling with enough air, which means less oxygen reaches your bloodstream. This deprives your organs of the oxygen they need to function." Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study - The Lancet Posted: 30 Jan 2020 12:00 AM PST [unable to retrieve full-text content] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study    The Lancet You are subscribed to email updates fro

“LSU SVM Center for Lung Biology and Disease investigates lung and lung-related heart diseases during the COVID-19 pandem - Science X” plus 2 more

Image
“LSU SVM Center for Lung Biology and Disease investigates lung and lung-related heart diseases during the COVID-19 pandem - Science X” plus 2 more LSU SVM Center for Lung Biology and Disease investigates lung and lung-related heart diseases during the COVID-19 pandem - Science X Case 1: A Full-Term Neonate with Trisomy 13 and Pneumoperitoneum - AAP News Preventive Strategies for Respiratory Syncytial Virus Infection in Young Infants - AAP News LSU SVM Center for Lung Biology and Disease investigates lung and lung-related heart diseases during the COVID-19 pandem - Science X Posted: 31 Jul 2020 06:46 AM PDT BATON ROUGE—Last year, the LSU School of Veterinary Medicine (LSU SVM) launched the Center for Lung Biology and Disease (CLBD) with more than $11.5 million in funding over five years from the National Institutes of Health, or NIH. No one involved could have predicted then that just one year later, a deadly new coronavir

“Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19 - Wiley” plus 2 more

Image
“Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19 - Wiley” plus 2 more Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19 - Wiley U of L conducting drug trial to treat COVID-19 patients in respiratory failure - WDRB Clinical Trial Tests Oral Cancer Drug to Combat Respiratory Symptoms of COVID-19 - Global Health News Wire Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19 - Wiley Posted: 30 Jul 2020 12:00 AM PDT 1 INTRODUCTION COVID 19 is a highly contagious respiratory tract infection caused by recently identified severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) originated from Wuhan, China (Wang et al., 2020 ). Unrestrained global spread of SARS‐CoV‐2 has resulted in 42,58,666 infected cases with ample number of reported deaths (2,94,